EUDA Health Holdings Ltd: EUDA Health Signs Important Tri-Party Memorandum of Understanding with GO POSB Organoids and Shenzhen Inno to Significantly Advance Next-Generation iPSC and NK-TCR Cell Thera
EUDA Health Holdings (NASDAQ: EUDA) said it signed a tri-party memorandum of understanding with GO POSB Organoids and Shenzhen Innovation Immunotechnology to collaborate on developing, manufacturing, and commercializing next-generation iPSC-derived off-the-shelf oncology cell therapies. The company framed the deal as advancing its commercialization and distribution strategy.




